Browse > Article
http://dx.doi.org/10.7314/APJCP.2013.14.11.6905

Trends in Epidemiology, Clinical and Histopathological Characteristics of Breast Cancer in Iran: Results of a 17 Year Study  

Afsharfard, Aboulfazl (Department of Surgery, Shohadaye Tajrish Hospital, Shahid Beheshti University of Medical Sciences)
Mozaffar, Mohammad (Department of Surgery, Shohadaye Tajrish Hospital, Shahid Beheshti University of Medical Sciences)
Orang, Elahe (Islamic Azad University, Tehran Medical Branch)
Tahmasbpour, Eisa (Young Research Club, Islamic Azad University)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.14, no.11, 2013 , pp. 6905-6911 More about this Journal
Abstract
Background: Breast cancer (BC) is the top cancer among women worldwide and the most frequent malignancy among Iranian women over the past few decades. The increasing trend and high mortality rate of BC in the developing world necessitates studies concentrating on its characteristics in countries in Asia. The current study focused on clinical and histopathological features of BC among Iranian females. Materials and Methods: This retrospective study involved 714 Iranian patients with histopathologically proven BC undergoing resection of primary tumours and axillary clearance. Demographic, clinical and histopathological data were obtained and studied between ten year age groups (${\leq}40$ years, 41-50 years, 51-60 years, 61-70 years, and ${\leq}71$ years) in four chronologic phases from 1994-2009. Results: Mean age of patients was $49.4{\pm}13.1$ years. Most of cases (33.2%) were in 41-50 group. Mean size of primary tumors was $3.94{\pm}2.47$ cm and 87.1% of cases had infiltrative ductal carcinoma. Modified radical mastectomy was the most common method of surgery carried out (48.8%). Some 57.1% of tumors were in pT2 and tumor size decreased significantly during the period (p<0.05). The most common BC stage was llla (27%). Lower BC stages (0 and 1) constituted 13.9% of the diagnosed tumors. Our series of patients aged ${\leq}40$ had larger tumors (mean $4.73{\pm}3.02$ cm) compared to older age groups (p=0.003). Lower stages (0 and I) were more frequent among the oldest patients while nearly 50% of patients aged ${\leq}40$ had tumor stage III. We also observed a significant decreasing trend in the mean LN count (p<0.05) and blood vessel invasion (p=0.023) from younger to older age groups. Conclusions: More aggressive disease for younger age groups, earlier peak incidence age and high rate of advanced BC at the time of diagnosis among Iranian women, were the main findings of this study.
Keywords
Breast cancer; epidemiology; staging; tumor type; trends; Iran;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Agarwal G, Pradeep PV, Aggarwal V, et al (2007). Spectrum of breast cancer in Asian women. World J Surg, 31, 1031-40.   DOI   ScienceOn
2 Benz CC (2008). Impact of aging on the biology of breast cancer. Crit Rev Oncol Hematol, 66, 65-74.   DOI   ScienceOn
3 Botteri E, Bagnardi V, Goldhirsch A, et al (2010). Axillary lymph node involvement in women with breast cancer: does it depend on age? Clin Breast Cancer, 10, 318-21.   DOI   ScienceOn
4 Colleoni M, Rotmensz N, Robertson C, et al (2002). Very young women (<35 years) with operable breast cancer: features of disease at presentation. Ann Oncol, 13, 273-9.
5 Fisher CJ, Egan MK, Smith P, et al (1997). Histopathology of breast cancer in relation to age. Br J Cancer, 75, 593-6.   DOI
6 Fleming ID, Cooper JS, Henson DE, et al (1997). American Joint Committee on Cancer: AJCC Cancer Staging Manual, 5th edition. Philadelphia, PA: Lippincott- Raven.
7 Foxcroft LM, Evans EB, Porter AJ (2004). The diagnosis of breast cancer in women younger than 40. Breast, 13, 2-306.
8 Gennari R, Curigliano G, Rotmensz N, et al (2004). Breast carcinoma in elderly women: features of disease presentation, choice of local and systemic treatments compared with younger postmenopasual patients. Cancer, 101, 1302-10.   DOI   ScienceOn
9 Harirchi I, Ebrahimi M, Zamani N, et al (2000). Breast cancer in Iran: a review of 903 case records. Public Health, 114, 143-5.
10 Harirchi I, Karbakhsh M, Kashefi A, et al (2004). Breast cancer in Iran: results of a multi-center study. Asian Pac J Cancer Prev, 5, 24-7.
11 Harirchi I, Karbakhsh M, Montazeri A, et al (2010). Decreasing trend of tumor size and downstaging in breast cancer in Iran: results of a 15-year study. Eur J Cancer Prev, 19, 126-30.   DOI   ScienceOn
12 Harirchi I, Kolahdoozan S, Karbakhsh M, et al (2011). Twenty years of breast cancer in Iran: downstaging without a formal screening program. Ann Oncol, 22, 93-7.   DOI   ScienceOn
13 Karihtala P, Winqvist R, Bloigu R, et al (2010). Long-term observational follow-up study of breast cancer diagnosed in women ${\leq}$40 years old. Breast, 19, 456-61.   DOI   ScienceOn
14 Medical Advisory Secretariat (2007). Screening Mammography for women aged 40 to 49 Years at average risk for breast cancer: an evidence-based analysis. Ontario Health Technology Assessment Series ,7, 1-29.
15 Mohammad K, Sadat Hashemi SM, Farahani FK (2004). Age at natural menopause in Iran. Maturitas, 49, 321-6.   DOI   ScienceOn
16 Molino A, Giovannini M, Auriemma A, et al (2006). Pathological, biological and clinical characteristics, and surgical management, of elderly women with breast cancer. Crit Rev Oncol Hematol, 59, 226-33.   DOI   ScienceOn
17 Mousavi SM, Montazeri A, Mohagheghi MA, et al (2007). Breast cancer in Iran: an epidemiological review. Breast J, 13, 383-91.   DOI   ScienceOn
18 Mousavi SM, Harirchi I, Ebrahimi M, et al (2008). Screening for breast cancer in Iran: a challenge for health policy makers. Breast J, 14, 605-6.   DOI   ScienceOn
19 Mousavi SM, Gouya MM, Ramazani R, et al (2009). Cancer incidence and mortality in Iran. Ann Oncol, 20, 556-63.
20 Orang E, Tahmasbpour E, Afsharfard A (2013). Predictive role of tumor size in breast cancer with axillary lymph node involvement - can size of primary tumor be used to omit an unnecessary axillary lymph node dissection? Asian Pac J Cancer Prev, 14, 717-22.   DOI   ScienceOn
21 Parkin DM, Bray F, Ferley J, et al (2001). Estimating the world cancer burden: Globocan 2000. Int J Cancer, 94, 153-6.   DOI   ScienceOn
22 Parkin DM, Fernandez LM (2006). Use of statistics to assess the global burden of breast cancer. Breast J, 12, 70-80.   DOI   ScienceOn
23 Porter PL (2009). Global trends in breast cancer incidence and mortality. Salud Publica Mex, 51, 141-6.   DOI
24 Sharma K, Costas A, Shulman LN, et al (2012). A systematic review of barriers to breast cancer care in developing countries resulting in delayed patient presentation. J Oncol, 121873.
25 Shibuya K, Mathers CD, Boschi-Pinto C, et al (2002). Global and regional estimates of cancer mortality and incidence by site: II. Results for the global burden of disease 2000. BMC Cancer, 2, 37.   DOI
26 Siegel R, Naishadham D, Jemal A (2013). Cancer statistics. CA Cancer J Clin, 63, 11-30.   DOI   ScienceOn
27 Smigal C, Jemal A, Ward E, et al (2006). Trends in breast cancer by race and ethnicity: update 2006. CA Cancer J Clin, 56, 168-83.   DOI   ScienceOn
28 Winchester DP, Osteen RT, Menck HR (1996). The National Cancer Data Base report on breast carcinoma characteristics and outcome in relation to age. Cancer, 78, 1838-43.   DOI
29 Yancik R, Wesley MN, Ries LA, et al (2001). Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older. JAMA, 285, 885-92.   DOI   ScienceOn